Product Information

LEVETIRACETAM ER 750 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.2500 per EA under NDC 50228019060. Its NADAC has been published 283 times since Jun 23, 2021.

FDA first approved this application on Nov 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM ER 750 MG TABLET

levetiracetam
$0.2500per EA

Strength

750 mg/1

NDC

50228019060

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA205130

FDA Approved

11/27/2020

TE Code

AB

On Market Since

11/27/2020

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM ER 750 MG TABLET has been published 283 times since Jun 23, 2021, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2500 per EA
All-time high$0.5896 (Jul 14, 2021)
All-time low$0.1819 (Nov 20, 2024)
52-week high$0.2613
52-week low$0.2104
Median price$0.2857
Average price$0.3041
Largest weekly change+50.1% (Aug 21, 2024)
Weeks tracked283
Tracking sinceJun 23, 2021

Price History

1W

+5.7%

1M

+11.9%

3M

+18.8%

6M

+2.4%

1Y

-5.9%

3Y

+6.9%

5Y

-43.1%

All

-57.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM ER 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM ER 750 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.2500 per EA (NDC 50228019060), effective Nov 18, 2026.

How has the price of LEVETIRACETAM ER 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM ER 750 MG TABLET has declined 57.6%. It has been tracked across 283 weekly CMS publications since Jun 23, 2021.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM ER 750 MG TABLET?

Since Jun 23, 2021, the NADAC for LEVETIRACETAM ER 750 MG TABLET has ranged from a low of $0.1819 (Nov 20, 2024) to a high of $0.5896 (Jul 14, 2021), with a median of $0.2857 per EA.

Are there cheaper alternatives to LEVETIRACETAM ER 750 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1162 per EA — about 54% below LEVETIRACETAM ER 750 MG TABLET.

Who manufactures LEVETIRACETAM ER 750 MG TABLET?

LEVETIRACETAM ER 750 MG TABLET (NDC 50228019060) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.